A empresa ViiV Healthcare que resulta de uma junção entre a GlaxoSmithKline e a Pfizer para investigar remédios para a Sida arranca

The company ViiV Healthcare is the result of a merge between GlaxoSmithKline and Pfizer to investigate remedies for AIDS, starts